COVID-19 Vaccination and Transient Increase in CD4/CD8 Cell Counts in People with HIV: Evidence from China

被引:0
|
作者
Li, Yanyan [1 ,2 ]
Lin, Yingying [3 ]
Yi, Yunyun [4 ]
Zhu, Na [1 ,2 ]
Cui, Xinyu [1 ,2 ]
Li, Xin [1 ,2 ,3 ]
机构
[1] Capital Med Univ, Beijing Ditan Hosp, Ctr Integrat Med, Beijing 100015, Peoples R China
[2] Capital Med Univ, Beijing Ditan Hosp, Natl Ctr Infect Dis, Beijing 100015, Peoples R China
[3] Peking Univ, Ditan Teaching Hosp, Ctr Integrat Med, Beijing 100015, Peoples R China
[4] Peoples Liberat Army Gen Hosp, Med Ctr 8, TB Prevent & Control Key Lab, Senior Dept TB,Beijing Key Lab New Tech TB Diag &, Beijing 100853, Peoples R China
关键词
HIV; COVID-19; vaccine; CD4; count; CD4/CD8; ratio; immune response; IMMUNOGENICITY; SARS-COV-2; SAFETY; RNA;
D O I
10.3390/vaccines12121365
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: Accumulating evidence has confirmed the efficacy and safety of COVID-19 vaccines against SARS-CoV-2 infection. However, the effect of COVID-19 vaccination on immuno-virological parameters in people with HIV (PWH) is uncertain. Methods: A total of 372 PWH treated at Beijing Ditan Hospital were included. Unvaccinated PWH were matched 1:3 with vaccinated PWH using a propensity score matching algorithm. Differences in immuno-virological markers between the matched groups were analyzed. The Wilcoxon signed rank test was used to test for changes in CD4 and CD8 counts and HIV viral load over two months around vaccination. In addition, we investigated the long-term changes in HIV-related markers in different vaccination dose groups and in the entire vaccinated population. Results: Vaccinated PWH had a higher CD4/CD8 ratio (0.64 (0.49, 0.78) vs. 0.80 (0.56, 1.03), p = 0.037) than unvaccinated PWH within a two-month window after the third dose. There were 337 PWH who received COVID-19 vaccination, and 73.9% (n = 249) received three doses of vaccine. We observed a transient increase in CD4 count and CD4/CD8 ratio within a two-month window after vaccination, especially after the second dose (CD4 count: 583.5 (428.5, 706.8) vs. 618.0 (452.0, 744.0), p = 0.018; CD4/CD8 ratio: 0.70 (0.50, 0.91) vs. 0.71 (0.53, 0.96), p < 0.001)) and the third dose (CD4 count: 575.5 (435.5, 717.0) vs. 577.5 (440.8, 754.8), p = 0.001; CD4/CD8 ratio: 0.70 (0.52, 0.93) vs. 0.79 (0.53, 1.00), p < 0.001)). Recent CD4 counts and CD4/CD8 ratios were lower than after COVID-19 but remained higher than before COVID-19 in vaccinated PWH. In addition, COVID-19 vaccination had no negative effect on HIV viral load. Conclusions: A transient increase in CD4 count and CD4/CD8 ratio was observed after COVID-19 vaccination. However, the enhanced cellular immune response induced by vaccination may diminish over time and return to normal levels. There is no adverse effect of vaccination on HIV viral load.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] A novel peripheral CD4(+)CD8(+) T cell population: Inheritance of CD8 alpha expression on CD4(+) T cells
    Luhtala, M
    Lassila, O
    Toivanen, P
    Vainio, O
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (01) : 189 - 193
  • [32] Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation
    Davy-Mendez, Thibaut
    Napravnik, Sonia
    Zakharova, Oksana
    Kuruc, JoAnn
    Gay, Cynthia
    Hicks, Charles B.
    Mcgee, Kara S.
    Eron, Joseph J.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 79 (04) : 510 - 518
  • [33] CD4/CD8 ratio, comorbidities, and aging in treated HIV infected individuals on viral suppression
    Passos, Daniela F.
    Bremm, Joao M.
    da Silveira, Leonardo L.
    Jantsch, Matheus H.
    da Silva, Jean L. G.
    Disconzi, Enzo
    Rezer, Joao F. P.
    Schwarzbold, Alexandre V.
    Marques, Angela C. F.
    Schetinger, Maria R. C.
    Leal, Daniela B. R.
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (12) : 3254 - 3264
  • [34] Visualization of CD4/CD8 T cell commitment
    Chan, S
    Correia-Neves, M
    Dierich, A
    Benoist, C
    Mathis, D
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12) : 2321 - 2333
  • [35] Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus
    Casado-Fernandez, Guiomar
    Canton, Juan
    Nasarre, Laura
    Ramos-Martin, Fernando
    Manzanares, Mario
    Sanchez-Menendez, Clara
    Fuertes, Daniel
    Mateos, Elena
    Murciano-Anton, Maria Aranzazu
    Perez-Olmeda, Mayte
    Cervero, Miguel
    Torres, Montserrat
    Rodriguez-Rosado, Rafael
    Coiras, Mayte
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [36] Chicken CD4, CD8αβ, and CD8αα T cell co-receptor molecules
    Luhtala, M
    POULTRY SCIENCE, 1998, 77 (12) : 1858 - 1873
  • [37] Evaluation of Immunoglobulins, CD4/CD8 T Lymphocyte Ratio and Interleukin-6 in COVID-19 Patients
    Saleh, Marwan Mahmood
    Jalil, Abduladheem Turki
    Abdulkareem, Rafid A.
    Suleiman, Ahmed AbdulJabbar
    TURKISH JOURNAL OF IMMUNOLOGY, 2020, 8 (03): : 129 - 134
  • [38] THE EFFECT OF PROPOLIS SUPPLEMENTATION TO CD4/CD8 RATIO IN HIV-INFECTED PATIENTS RECEIVING ANTIRETROVIRAL REGIMEN THERAPY
    Triyono, E. A.
    Firdausa, S.
    Prasetyo, H.
    Susanto, J.
    Hutagalung, J.
    Masyfufah, L.
    Hadi, U.
    NEW ARMENIAN MEDICAL JOURNAL, 2019, 13 (04): : 85 - 94
  • [39] Active Tuberculosis Is Associated with Depletion of HIV-Specific CD4 and CD8 T Cells in People with HIV
    Khayumbi, Jeremiah
    Sasser, Loren E.
    McLaughlin, Taryn A.
    Muchiri, Benson
    Ongalo, Joshua
    Tonui, Joan
    Ouma, Samuel Gurrion
    Campbell, Angie
    Odhiambo, Felix Hayara
    Kiprotich, Chelimo
    Gandhi, Neel R.
    Day, Cheryl L.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2024, 40 (07) : 417 - 427
  • [40] CD4+and CD8+cell counts are significantly correlated with absolute lymphocyte count in hospitalized COVID-19 patients: a retrospective study
    Liana, Phey
    Samosir, Aprilia Paskah
    Sari, Nurmalia Purnama
    Andriani, Raden Ayu Linda
    Verdiansah, Verdiansah
    Hidayatullah, Hidayatullah
    Ahmad, Zen
    Umar, Tungki Pratama
    PEERJ, 2023, 11